ArticleNature communications2026
Two Plasmodium vivax hypnozoite-expressed RNA-binding proteins inhibit liver stage replication.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Update ofTwo2025
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Plasmodium vivax (Pv) forms non-replicating liver stages called hypnozoites, which activate after primary infection, and cause relapses of symptomatic blood-stage malaria. We hypothesize that hypnozoites must actively suppress schizogony to maintain a quiescent state. Differential transcriptome prospecting identifies two hypnozoite-expressed transcripts encoding putative RNA-binding proteins. We assess the functional role of the two encoded proteins in Plasmodium yoelii (Py), a rodent malaria parasite that naturally does not form hypnozoites. Strikingly, individual expression of each protein in Py liver stages blocks liver stage schizogony, with parasites remaining small and uninucleate. A screen of RNA sequences that interact with the putative RNA-binding domains of these proteins shows enrichment of distinct, highly specific motifs, indicating that they might block schizogony by binding RNAs containing these motifs. Our findings provide the unprecedented functional evidence for one potential molecular mechanism of hypnozoite formation. Based on their function we name these proteins IESI-1 and IESI-2 (Initiation of Exo-erythrocytic Schizogony Inhibited).
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.